Health Care & Life Sciences » Biotechnology | Shanghai RAAS Blood Products Co. Ltd.

Shanghai RAAS Blood Products Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
489
1,312
2,006
2,312
1,912
1,788
Cost of Goods Sold (COGS) incl. D&A
182
512
805
858
735
657
Gross Income
307
800
1,201
1,454
1,177
1,131
SG&A Expense
125
219
360
335
396
667
EBIT
182
582
841
1,119
775
434
Unusual Expense
-
2
865
156
173
1,027
Non Operating Income/Expense
4
26
7
665
433
1,127
Interest Expense
16
24
22
35
71
66
Pretax Income
169
602
1,749
1,959
1,003
1,741
Income Tax
26
91
269
309
173
233
Equity in Affiliates
-
-
-
-
1
15
Consolidated Net Income
143
511
1,480
1,650
832
1,523
Net Income
144
511
1,442
1,613
836
1,518
Net Income After Extraordinaries
144
511
1,442
1,613
836
1,518
Net Income Available to Common
144
511
1,442
1,613
836
1,518
EPS (Basic)
0.04
0.13
0.29
0.33
0.17
0.31
Basic Shares Outstanding
3,525
4,087
4,961
4,966
4,970
4,975
EPS (Diluted)
0.04
0.13
0.29
0.32
0.17
0.31
Diluted Shares Outstanding
3,525
4,087
4,961
4,966
4,970
4,975
EBITDA
199
642
946
1,217
910
591
Other Operating Expense
-
-
-
2
6
29
Non-Operating Interest Income
5
15
34
54
39
28
Minority Interest Expense
1
-
38
37
4
5

About Shanghai RAAS Blood Products Co.

View Profile
Address
No. 2009 Wangyuan Road
Shanghai Shanghai 201401
China
Employees -
Website http://www.raas-corp.com
Updated 07/08/2019
Shanghai RAAS Blood Products Co., Ltd. engages in the production and sale of blood products. It provides testing services for blood, vaccines, diagnostic reagents, and testing equipment. Its products include human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.